Impact of primary graft failure on outcomes following lung transplantation

被引:179
作者
Christie, JD
Sager, JS
Kimmel, SE
Ahya, VN
Gaughan, C
Blumenthal, NP
Kotloff, RM
机构
[1] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Div Pulm Allergy & Crit Care Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Div Cardiovasc Med, Dept Med, Philadelphia, PA 19104 USA
关键词
acute lung injury; complications; lung transplantation; outcomes; reperfusion injury;
D O I
10.1378/chest.127.1.161
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objectives: Primary graft failure (PGF) is a severe acute lung injury syndrome that occurs following lung transplantation. We compared the clinical outcomes of patients who developed PGF with those who did not. Methods: We conducted a retrospective cohort study including 255 consecutive lung transplant procedures. PGF was defined as (1) diffuse alveolar opacities developing within 72 h of transplantation, (2) an arterial partial pressure of oxygen/fraction of inspired oxygen (PaO2/FIO2) ratio of < 200 beyond 48 h postoperatively, and (3) no other secondary cause of graft dysfunction. PGF was tested for acceptance with 30-day and all-cause hospital mortality rates, overall survival, hospital length of stay (HLOS), duration of mechanical ventilation, and best 6-min walk test (6MWT) distance achieved within 12 months. Setting: Academic medical center. Results: The overall incidence of PGF was 11.8% (95% confidence interval [CI], 7.9 to 15.9%). The all-cause mortality rate at 30 days was 63.3% in patients with PGF and 8.8% in patients without PGF (relative risk [R-R], 7.15; 95% CI, 4.34 to 11.80%; p < 0.001). A total of 73.3% of patients with PGF died during hospitalization vs 14.2% of patients without PGF (RR, 5.18%; 95% CI, 3.51 to 7.63; p < 0.001). The median HLOS in 30-day survivors was 47 days in patients with PGF vs 15 days in those without PGF (p < 0.001), and the mean duration of mechanical ventilation was 15 days in patients with PGF vs I day in those without PGF (p < 0.001). By 12 months, a total of 28.5% of survivors with PGF achieved a normal age-appropriate 6MWT distance vs 71.4% of survivors without PGF at 12 months (p = 0.014). The median best 6MWT distance achieved within the first 12 months was 1,196 feet in patients with PGF vs; 1,546 feet in those without PGF (p = 0.009). Conclusions: PGF has a significant impact on mortality, HLOS, and duration of mechanical ventilation following lung transplantation. Survivors of PGF have a protracted recovery with impaired physical function up to 1 year following transplantation.
引用
收藏
页码:161 / 165
页数:5
相关论文
共 20 条
[1]   Quality-adjusted survival in the first year after the acute respiratory distress syndrome [J].
Angus, DC ;
Musthafa, AA ;
Clermont, G ;
Griffin, MF ;
Linde-Zwirble, WT ;
Dremsizov, TT ;
Pinsky, MR .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (06) :1389-1394
[2]   Medical progress - Lung transplantation [J].
Arcasoy, SM ;
Kotloff, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (14) :1081-1091
[3]   THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION [J].
BERNARD, GR ;
ARTIGAS, A ;
BRIGHAM, KL ;
CARLET, J ;
FALKE, K ;
HUDSON, L ;
LAMY, M ;
LEGALL, JR ;
MORRIS, A ;
SPRAGG, R ;
COCHIN, B ;
LANKEN, PN ;
LEEPER, KV ;
MARINI, J ;
MURRAY, JF ;
OPPENHEIMER, L ;
PESENTI, A ;
REID, L ;
RINALDO, J ;
VILLAR, J ;
VANASBECK, BS ;
DHAINAUT, JF ;
MANCEBO, J ;
MATTHAY, M ;
MEYRICK, B ;
PAYEN, D ;
PERRET, C ;
FOWLER, AA ;
SCHALLER, MD ;
HUDSON, LD ;
HYERS, T ;
KNAUS, W ;
MATTHAY, R ;
PINSKY, M ;
BONE, RC ;
BOSKEN, C ;
JOHANSON, WG ;
LEWANDOWSKI, K ;
REPINE, J ;
RODRIGUEZROISIN, R ;
ROUSSOS, C ;
ANTONELLI, MA ;
BELOUCIF, S ;
BIHARI, D ;
BURCHARDI, H ;
LEMAIRE, F ;
MONTRAVERS, P ;
PETTY, TL ;
ROBOTHAM, J ;
ZAPOL, W .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :818-824
[4]   Respiratory failure after lung transplantation [J].
Chatila, WM ;
Furukawa, S ;
Gaughan, JP ;
Criner, GJ .
CHEST, 2003, 123 (01) :165-173
[5]   Clinical risk factors for primary graft failure following lung transplantation [J].
Christie, JD ;
Kotloff, RM ;
Pochettino, A ;
Arcasoy, SM ;
Rosengard, BR ;
Landis, JR ;
Kimmel, SE .
CHEST, 2003, 124 (04) :1232-1241
[6]   Primary graft failure following lung transplantation [J].
Christie, JD ;
Bavaria, JE ;
Palevsky, HI ;
Litzky, L ;
Blumenthal, NP ;
Kaiser, LR ;
Kotloff, RM .
CHEST, 1998, 114 (01) :51-60
[7]  
Collett D, 2014, MODELLING SURVIVAL D
[8]   Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients [J].
Davidson, TA ;
Caldwell, ES ;
Curtis, JR ;
Hudson, LD ;
Steinberg, KP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (04) :354-360
[9]   Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation [J].
De Perrot, M ;
Sekine, Y ;
Fischer, S ;
Waddell, TK ;
McRae, K ;
Liu, MY ;
Wigle, DA ;
Keshavjee, S .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (02) :211-215
[10]   Reference equations for the six-minute walk in healthy adults [J].
Enright, PL ;
Sherrill, DL .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (05) :1384-1387